Patent details

EP2182940 Title: USE OF TETRAHYDROCANNABINOL AND/OR CANNABIDIOL FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE

Basic Information

Publication number:
EP2182940
PCT Application Number:
PCT/GB/2008/002183
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP087624896
PCT Publication Number:
WO/2009/004302
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF TETRAHYDROCANNABINOL AND/OR CANNABIDIOL FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
French Title of Invention:
UTILISATION DE TÉTRAHYDROCANNABINOL ET/OU DU CANNABIDIOL POUR LE TRAITEMENT D'UNE MALADIE INFLAMMATOIRE DE L'INTESTIN
German Title of Invention:
VERWENDUNG VON TETRAHYDROCANNABINOL UND/ODER CANNABIDIOL ZUR BEHANDLUNG VON ENTZÜNDLICHER DARMERKRANKUNG
SPC Number:

Dates

Filing date:
25/06/2008
Grant date:
12/03/2014
EP Publication Date:
12/03/2014
PCT Publication Date:
08/01/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
12/05/2010
EP B1 Publication Date:
12/03/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
25/06/2014
Expiration date:
25/06/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
25/06/2008
 
 

Name:
GW Pharma Limited
Address:
Porton Down Science Park, Salisbury Wiltshire SP4 0JR, United Kingdom (GB)

Inventor

1

Name:
JAMONTT Joanna
Address:
United Kingdom (GB)

2

Name:
PERTWEE Roger
Address:
United Kingdom (GB)

3

Name:
GUY Geoffrey
Address:
United Kingdom (GB)

4

Name:
ROBSON Philip
Address:
United Kingdom (GB)

Priority

Priority Number:
0713083
Priority Date:
05/07/2007
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
A61K 31/352;
Filing date Document type Number of pages